Latest filing published 26 Aug 2026 for Bristol Myers Squibb Co, €29k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Phil M. Holzer discloses dealings in Bristol Myers Squibb Co to SEC (Form 4). We count 32 filings; the first trade dates from 10 March 2024 and the latest from 25 August 2026.
The open-market record consists of 2 sales worth €65k, with no purchase. Other entries cover 10 share grants and 10 option exercises. Since January 2026: no purchases and 1 sale on the market.
The latest filing, published on 26 August 2026, reports an open-market sale of €29k in Bristol Myers Squibb Co. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations